Latest Capital Raise News

Southern Palladium has made significant strides in advancing its Bengwenyama platinum group metals project, completing key drilling and regulatory milestones while securing A$20 million in fresh capital to fund the next development phase.

C29 Metals is progressing drilling plans at its Samsons Tank Copper project in NSW while securing a $150,000 convertible loan from a director and exploring global acquisition opportunities to diversify its portfolio.

Cobalt Blue Holdings has enhanced the financial outlook for its Kwinana Cobalt Refinery project, secured a $5.3 million capital raise, and advanced key environmental and feedstock initiatives amid a tightening cobalt market.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

HITIQ has made significant strides in expanding its concussion management technology, PROTEQT©, into North America and Australian retail, backed by strong research partnerships and a successful capital raise.

IPB Petroleum is set to expand its footprint into Alaska’s National Petroleum Reserve with a major lease acquisition, supported by a recent $1.27 million capital raise. The company also plans a rebrand to Forte Energy, signalling a new chapter.

Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.

Terra Critical Minerals has completed a key acquisition in Nevada and boosted its Canadian uranium investment, positioning itself to capitalise on soaring tungsten and uranium prices.

Dundas Minerals has secured an 80% interest in the Romano Gold Project near the Gruyere Mine and raised $1.1 million to accelerate exploration and development. New leadership and advanced AI targeting signal a strategic push into Western Australia's prolific gold belts.

Actinogen Medical has completed enrolment for its pivotal XanaMIA Alzheimer's trial ahead of schedule, with a positive interim analysis supporting continuation. The company is gearing up for an open-label extension and advancing commercial and partnership strategies.

Native Mineral Resources Holdings Limited reported a modest operating cash outflow in December 2025 but expects improved liquidity following recent gold sales and a $3 million convertible note raise.

Biotron Limited has successfully closed its fully subscribed rights issue, raising $1.52 million, and completed the acquisition of Sedarex Limited, positioning itself for growth in its diversified biotech portfolio.